Literature DB >> 21741960

Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR.

Yanwei Zhong1, Jiaqi Han, Zhengsheng Zou, Shuhong Liu, Bo Tang, Xiaoqiang Ren, Xiaodong Li, Yulai Zhao, Yan Liu, Dongqing Zhou, Weijie Li, Jingmin Zhao, Dongping Xu.   

Abstract

BACKGROUND: The study aimed to develop an effective method to quantitate HBV covalently closed circular DNA (cccDNA) using small section of formalin fixed paraffin-embedded (FFPE) liver biopsy.
METHODS: Plasmid-safe ATP-dependent DNase (PSAD)-treated samples were subjected to rolling circle amplification (RCA) prior to real-time PCR mediated by cccDNA-selective primers. Human beta-actin gene was used as a reference control.
RESULTS: Compared to the classical method, i.e., PSAD digestion+real-time PCR, introduction of RCA increased the lower limit of detection for about 2 logs with good inter- and intra-assay reproducibility. HBV cccDNA was detected in 91.5% (119/130) of the FFPE samples. The cccDNA levels (copy/cell) between FFPE liver tissues and fresh frozen counterpart tissues were comparable. The median of cccDNA level in HBeAg-positive patients was higher than that in HBeAg-negative ones (52.60 vs. 31.25copies/cell, P<0.01). Intrahepatic cccDNA level was positively correlated with intrahepatic HBV total DNA level, but not obviously correlated with serum HBV DNA or alanine aminotransferase levels.
CONCLUSIONS: The method could sensitively and specifically quantitate intrahepatic HBV cccDNA in micro FFPE liver biopsy tissue for evaluation of HBV replication status in the liver.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741960     DOI: 10.1016/j.cca.2011.06.031

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  19 in total

1.  The preS deletion of hepatitis B virus (HBV) is associated with liver fibrosis progression in patients with chronic HBV infection.

Authors:  Fan Li; Xiaodong Li; Tao Yan; Yan Liu; Yongqian Cheng; Zhihui Xu; Qing Shao; Hao Liao; Pengyu Huang; Jin Li; Guo-Feng Chen; Dongping Xu
Journal:  Hepatol Int       Date:  2018-04-12       Impact factor: 6.047

2.  Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation.

Authors:  Wei Rao; Man Xie; Tao Yang; Jian-Jun Zhang; Wei Gao; Yong-Lin Deng; Hong Zheng; Cheng Pan; Yi-He Liu; Zhong-Yang Shen
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication.

Authors:  Jie Wang; Zhong-Wei Xu; Shuang Liu; Rui-Yang Zhang; Shan-Long Ding; Xiao-Meng Xie; Lu Long; Xiang-Mei Chen; Hui Zhuang; Feng-Min Lu
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

4.  The correlation between T helper type 17 cells and clinical characters in Chinese paediatric patients with chronic hepatitis B.

Authors:  S Zhu; H Zhang; Y Dong; Z Xu; D Chen; L Wang; Y Gan; F Wang; Y Wang; X Xing; S Hu; Z Li; L Long; L Liu; Y Zhong
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

5.  A novel method for detection of HBVcccDNA in hepatocytes using rolling circle amplification combined with in situ PCR.

Authors:  Yanwei Zhong; Shuangye Hu; Chen Xu; Yulai Zhao; Dongping Xu; Yanqing Zhao; Jingmin Zhao; Zhibin Li; Xiuchang Zhang; Hongfei Zhang; Jin Li
Journal:  BMC Infect Dis       Date:  2014-12-03       Impact factor: 3.090

6.  The gRNA-miRNA-gRNA Ternary Cassette Combining CRISPR/Cas9 with RNAi Approach Strongly Inhibits Hepatitis B Virus Replication.

Authors:  Jie Wang; Ran Chen; Ruiyang Zhang; Shanlong Ding; Tianying Zhang; Quan Yuan; Guiwen Guan; Xiangmei Chen; Ting Zhang; Hui Zhuang; Frederick Nunes; Timothy Block; Shuang Liu; Zhongping Duan; Ningshao Xia; Zhongwei Xu; Fengmin Lu
Journal:  Theranostics       Date:  2017-07-22       Impact factor: 11.556

7.  Analysis of hepatitis B virus intrahepatic covalently closed circular DNA and serum viral markers in treatment-naive patients with acute and chronic HBV infection.

Authors:  Weijie Li; Jingmin Zhao; Zhengsheng Zou; Yan Liu; Baosen Li; Ying Sun; Xiaodong Li; Shuhong Liu; Shaoping Cai; Weiming Yao; Weimin Yao; Shaojie Xin; Fengmin Lu; Dongping Xu
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

8.  An Effective Molecular Target Site in Hepatitis B Virus S Gene for Cas9 Cleavage and Mutational Inactivation.

Authors:  Hao Li; Chunyu Sheng; Hongbo Liu; Guangze Liu; Xinying Du; Juan Du; Linsheng Zhan; Peng Li; Chaojie Yang; Lihua Qi; Jian Wang; Xiaoxia Yang; Leili Jia; Jing Xie; Ligui Wang; Rongzhang Hao; Dongping Xu; Yigang Tong; Yusen Zhou; Jianjun Zhou; Yansong Sun; Qiao Li; Shaofu Qiu; Hongbin Song
Journal:  Int J Biol Sci       Date:  2016-08-05       Impact factor: 6.580

9.  Detection of Hepatitis B Virus Covalently Closed Circular DNA in the Plasma of Iranian HBeAg-Negative Patients With Chronic Hepatitis B.

Authors:  Zahra Tajik; Hossein Keyvani; Farah Bokharaei-Salim; Mohammad Reza Zolfaghari; Shahin Fakhim; Maryam Keshvari; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2015-09-29       Impact factor: 0.660

10.  MitoRCA-seq reveals unbalanced cytocine to thymine transition in Polg mutant mice.

Authors:  Ting Ni; Gang Wei; Ting Shen; Miao Han; Yaru Lian; Haihui Fu; Yan Luo; Yanqin Yang; Jie Liu; Yoshi Wakabayashi; Zheng Li; Toren Finkel; Hong Xu; Jun Zhu
Journal:  Sci Rep       Date:  2015-07-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.